Form 13-F position report

KALVISTA PHARMACEUTICALS IN

Reported by SPHERA FUNDS MANAGEMENT LTD

KALV CUSIP 483497103 Manager CIK 0001496201

Reported 0 shares, down 316,200 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2022
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 2 Through Q1 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 4183000
2022-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

2 quarters
Quarterly reported position history for KALVISTA PHARMACEUTICALS IN held by SPHERA FUNDS MANAGEMENT LTD.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2022 Reduced 0 -316,200 (-100.0%) 0 $0 2022-05-16
Q4 2021 New 316,200 +316,200 (0.0%) 0.46% $4,183,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

104 managers reported KALVISTA PHARMACEUTICALS IN for Q1 2022.

Managers reporting KALVISTA PHARMACEUTICALS IN in Q1 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
RA CAPITAL MANAGEMENT L P Unchanged 1,930,322 0 0.62% $28,453,000 5 qtrs
SUVRETTA CAPITAL MANAGEMENT LLC Unchanged 1,746,300 0 0.79% $25,740,000 9 qtrs
Deep Track Capital LP Added 1,729,757 +229,757 1.64% $25,497,000 2 qtrs
Frazier Life Sciences Management L P New 1,572,192 +1,572,192 1.97% $23,174,000 1 qtr
BlackRock Inc Added 1,544,027 +39,407 < 0.01% $22,757,000 21 qtrs
Vivo Capital LLC Unchanged 1,533,559 0 1.56% $22,605,000 9 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 1,346,742 -464,763 < 0.01% $19,851,000 11 qtrs
FRANKLIN RESOURCES INC Reduced 1,239,731 -12,411 < 0.01% $18,273,000 10 qtrs
VANGUARD GROUP INC Added 1,166,652 +28,168 < 0.01% $17,196,000 22 qtrs
STATE STREET CORPORATION Reduced 938,867 -113,109 < 0.01% $13,839,000 13 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2022
Filed
May 16, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.